Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

⏱ Horizon: Long
🔢 Total funds: 12
💰 Total AUM: 17,581 Cr

Best performing Sectoral Fund - Pharma & Health Care

Name	AUM (Cr)	Exp Ratio (%)	1Y Return	3Y CAGR	5Y CAGR

To view more Sectoral Fund - Pharma & Health Care

Visit Screener

Overview of Sectoral Fund - Pharma & Health Care

DSP Healthcare Fund

AUM
₹ 1,717.54 Cr.
Expense Ratio
0.71%
5Y CAGR
25.4%

Performance

The fund's annualised performance has been 25.15% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 10.09% vs its category average of 10.12%.

Composition

Small Cap makes up for the majority of the fund at 35.17% along with the largest allocation towards Pharmaceuticals at 75.4%.

Mirae Asset Healthcare Fund

AUM
₹ 1,783.19 Cr.
Expense Ratio
0.56%
5Y CAGR
23.91%

Performance

The fund's annualised performance has been 22.19% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 10.42% vs its category average of 10.12%.

Composition

Large Cap makes up for the majority of the fund at 48.87% along with the largest allocation towards Pharmaceuticals at 73.45%.

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund

AUM
₹ 3,270.55 Cr.
Expense Ratio
1.15%
5Y CAGR
23.09%

Performance

The fund's annualised performance has been 20.81% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 9.68% vs its category average of 10.12%.

Composition

Large Cap makes up for the majority of the fund at 46.79% along with the largest allocation towards Pharmaceuticals at 72.26%.

Tata India Pharma & Healthcare Fund

AUM
₹ 752.94 Cr.
Expense Ratio
0.93%
5Y CAGR
22.16%

Performance

The fund's annualised performance has been 12.03% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 10.49% vs its category average of 10.12%.

Composition

Large Cap makes up for the majority of the fund at 41.56% along with the largest allocation towards Pharmaceuticals at 79.94%.

Nippon India Pharma Fund

AUM
₹ 5,539.19 Cr.
Expense Ratio
0.97%
5Y CAGR
21.48%

Performance

The fund's annualised performance has been 17.61% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 10.35% vs its category average of 10.12%.

Composition

Large Cap makes up for the majority of the fund at 39.58% along with the largest allocation towards Pharmaceuticals at 81.23%.

SBI Healthcare Opp Fund

AUM
₹ 2,169.41 Cr.
Expense Ratio
1.04%
5Y CAGR
21.37%

Performance

The fund's annualised performance has been 16.85% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 9.81% vs its category average of 10.12%.

Composition

Large Cap makes up for the majority of the fund at 35.82% along with the largest allocation towards Pharmaceuticals at 64.31%.

UTI Healthcare Fund

AUM
₹ 852.86 Cr.
Expense Ratio
1.4%
5Y CAGR
20.45%

Performance

The fund's annualised performance has been 14.97% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 9.64% vs its category average of 10.12%.

Composition

Large Cap makes up for the majority of the fund at 41.06% along with the largest allocation towards Pharmaceuticals at 75.12%.

Aditya Birla SL Pharma & Healthcare Fund

AUM
₹ 565.11 Cr.
Expense Ratio
1.1%
5Y CAGR
0%

Performance

The fund's annualised performance has been 22.35% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 10.36% vs its category average of 10.12%.

Composition

Large Cap makes up for the majority of the fund at 42.09% along with the largest allocation towards Pharmaceuticals at 77%.

LIC MF Healthcare Fund

AUM
₹ 48.34 Cr.
Expense Ratio
1.21%
5Y CAGR
0%

Performance

The fund's annualised performance has been 17.91% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 10.65% vs its category average of 10.12%.

Composition

Large Cap makes up for the majority of the fund at 47.74% along with the largest allocation towards Pharmaceuticals at 73.49%.

ITI Pharma & Healthcare Fund

AUM
₹ 128.75 Cr.
Expense Ratio
0.43%
5Y CAGR
0%

Performance

The fund's annualised performance has been 10.82% since inception.

Risk

The fund has been categorised as Very High by SEBI and has a standard deviation of 10.02% vs its category average of 10.12%.

Composition

Large Cap makes up for the majority of the fund at 38.64% along with the largest allocation towards Pharmaceuticals at 75.33%.

This compilation has been made as and by way of an update from the publicly available sources of information.This compilation is provided for information purposes only and is not intended to be relied upon by any party as the basis of any decision.

While every effort has been made to take due care in publishing this compilation and to avoid errors or omissions, this compilation is published with a condition and understanding that the Anchorage Technologies Private Limited (ATPL) shall not be responsible for any damages, compensation or loss or action taken or abstained to be taken on the basis of this article/commentary to any person whomsoever.

Investing in Mutual Funds,Stocks/ETFs (Exchange Traded Funds) and securities are subject to market risk. Please read all the related documents carefully before investing. Investors should consider all risk factors and consult their financial advisor before investing. Representations are not indicative of future results.